Proteolytic intermediates in the oligomerisation-aggregation pathway of alpha-synuclein revealed by ion mobility mass spectrometry
Proteolytic intermediates in the oligomerisation-aggregation pathway of alpha-synuclein revealed by ion mobility mass spectrometry
No Thumbnail Available
Files
There are no files associated with this item.
Date
2010
Authors
Editors
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
DOI (citable link)
International patent number
Link to the license
EU project number
Project
Open Access publication
Collections
Title in another language
Publication type
Journal article
Publication status
Published
Published in
Journal of Peptide Science ; 16 (2010), S1. - pp. 43. - Wiley. - ISSN 1075-2617. - eISSN 1099-1387
Abstract
A variety of diseases, previously thought to be unrelated, such as cancer and neurodegenerative diseases, are characterised by the formation of ”misfolded”protein aggregates. While ”soft-ionisation”mass spectrometry (MS), particularly electrospray-MS (ESI-MS), has substantially contributed to peptide analysis and proteomics, ESI-MS is not suitable to direct ”in-situ”analysis of conformational states and intermediates. Recently, ion mobility mass spectrometry (IM-MS) is emerging as a new tool to probe protein structures and interactions due to its potential for separation polypeptides by conformational states, shape and topology. We report here first applications of IM-MS to the characterization of reaction intermediates in the in vitro oligomerisation and aggregation of alpha-synuclein (αSyn), a key polypeptide in Parkinson’s disease. IM-MS of the in vitro aggregation of wt-αSyn enabled the structure elucidation of several hitherto unknown N- and C-terminal products, and a proteolytic fragment at V71-T72 in the aggregation domain (C-VT72; 7.2 kDa), which appears to be a key intermediate in the aggregation pathway; in vitro studies of this fragment prepared by chemical synthesis and bacterial expression showed a dramatically enhanced rate of aggregation. Most recently, IM-MS was also successfully applied to the direct analysis of affinity-captured αSyn from biological samples, such as brain homogenate, indicating this method as a powerful new tool to the molecular characterization of conformation-dependant intermediates of protein aggregation.
Summary in another language
Subject (DDC)
570 Biosciences, Biology
Keywords
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690
PRZYBYLSKI, Michael, Camelia VLAD, Kathrin LINDNER, Thomas CIOSSEK, Bastian HENGERER, Marcel LEIST, 2010. Proteolytic intermediates in the oligomerisation-aggregation pathway of alpha-synuclein revealed by ion mobility mass spectrometry. In: Journal of Peptide Science. Wiley. 16(S1), pp. 43. ISSN 1075-2617. eISSN 1099-1387. Available under: doi: 10.1002/psc.1301BibTex
@article{Przybylski2010Prote-52627, year={2010}, doi={10.1002/psc.1301}, title={Proteolytic intermediates in the oligomerisation-aggregation pathway of alpha-synuclein revealed by ion mobility mass spectrometry}, number={S1}, volume={16}, issn={1075-2617}, journal={Journal of Peptide Science}, author={Przybylski, Michael and Vlad, Camelia and Lindner, Kathrin and Ciossek, Thomas and Hengerer, Bastian and Leist, Marcel}, note={Meeting Abstract} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/52627"> <dc:contributor>Vlad, Camelia</dc:contributor> <dc:contributor>Lindner, Kathrin</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T12:14:20Z</dcterms:available> <dcterms:title>Proteolytic intermediates in the oligomerisation-aggregation pathway of alpha-synuclein revealed by ion mobility mass spectrometry</dcterms:title> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-01-29T12:14:20Z</dc:date> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:creator>Ciossek, Thomas</dc:creator> <dcterms:issued>2010</dcterms:issued> <dc:creator>Przybylski, Michael</dc:creator> <dc:language>eng</dc:language> <dc:creator>Leist, Marcel</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/52627"/> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:contributor>Przybylski, Michael</dc:contributor> <dc:creator>Lindner, Kathrin</dc:creator> <dc:contributor>Ciossek, Thomas</dc:contributor> <dc:rights>terms-of-use</dc:rights> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:abstract xml:lang="eng">A variety of diseases, previously thought to be unrelated, such as cancer and neurodegenerative diseases, are characterised by the formation of ”misfolded”protein aggregates. While ”soft-ionisation”mass spectrometry (MS), particularly electrospray-MS (ESI-MS), has substantially contributed to peptide analysis and proteomics, ESI-MS is not suitable to direct ”in-situ”analysis of conformational states and intermediates. Recently, ion mobility mass spectrometry (IM-MS) is emerging as a new tool to probe protein structures and interactions due to its potential for separation polypeptides by conformational states, shape and topology. We report here first applications of IM-MS to the characterization of reaction intermediates in the in vitro oligomerisation and aggregation of alpha-synuclein (αSyn), a key polypeptide in Parkinson’s disease. IM-MS of the in vitro aggregation of wt-αSyn enabled the structure elucidation of several hitherto unknown N- and C-terminal products, and a proteolytic fragment at V71-T72 in the aggregation domain (C-VT72; 7.2 kDa), which appears to be a key intermediate in the aggregation pathway; in vitro studies of this fragment prepared by chemical synthesis and bacterial expression showed a dramatically enhanced rate of aggregation. Most recently, IM-MS was also successfully applied to the direct analysis of affinity-captured αSyn from biological samples, such as brain homogenate, indicating this method as a powerful new tool to the molecular characterization of conformation-dependant intermediates of protein aggregation.</dcterms:abstract> <dc:creator>Hengerer, Bastian</dc:creator> <dc:creator>Vlad, Camelia</dc:creator> <dc:contributor>Hengerer, Bastian</dc:contributor> <dc:contributor>Leist, Marcel</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> </rdf:Description> </rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Examination date of dissertation
Method of financing
Comment on publication
Meeting Abstract
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
Yes
Refereed
No